NCAM1 and COVID-19: Metacluster #1 was more frequent in healthy donors than in COVID-19 patients and was characterized by CD4+ T cells expressing early differentiation markers (CD62L+CD95+CD127+CD28+) and low levels of KLRG1 and CD56 (Figure 4D; Supplementary Figure 9A).